14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Jan 14, 2019 $9.11 $9.46 $8.73 $8.75 558 513
Jan 11, 2019 $9.30 $9.33 $9.06 $9.22 493 222
Jan 10, 2019 $9.35 $9.83 $9.12 $9.32 568 255
Jan 09, 2019 $9.54 $9.54 $9.20 $9.37 418 622
Jan 08, 2019 $9.78 $9.91 $9.41 $9.56 377 467
Jan 07, 2019 $10.00 $10.65 $9.38 $9.62 948 959
Jan 04, 2019 $9.35 $9.46 $8.91 $9.21 324 084
Jan 03, 2019 $9.00 $9.78 $8.92 $9.26 567 217
Jan 02, 2019 $8.36 $9.23 $8.22 $9.07 349 771
Dec 31, 2018 $8.45 $8.64 $8.25 $8.54 308 341
Dec 28, 2018 $8.48 $8.64 $8.16 $8.45 365 761
Dec 27, 2018 $8.16 $8.54 $7.87 $8.45 567 943
Dec 26, 2018 $7.83 $8.37 $7.71 $8.33 582 259
Dec 24, 2018 $7.82 $8.16 $7.46 $7.75 408 305
Dec 21, 2018 $7.84 $8.34 $7.48 $7.84 3 226 427
Dec 20, 2018 $7.84 $7.97 $7.42 $7.78 745 519
Dec 19, 2018 $8.13 $8.50 $7.64 $7.86 983 987
Dec 18, 2018 $8.85 $8.98 $7.97 $8.10 953 767
Dec 17, 2018 $9.23 $9.42 $8.76 $8.78 689 931
Dec 14, 2018 $9.39 $9.76 $9.28 $9.30 597 168
Dec 13, 2018 $9.60 $9.78 $9.45 $9.48 393 176
Dec 12, 2018 $9.66 $9.87 $9.66 $9.69 349 394
Dec 11, 2018 $10.00 $10.00 $9.52 $9.55 301 592
Dec 10, 2018 $9.95 $10.06 $9.26 $9.81 417 977
Dec 07, 2018 $9.97 $10.20 $9.80 $9.98 413 660
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT